CD4 and neoplasm: Furthermore, we found that LUAD patients in the high‐risk group had higher infiltration of tumor‐infiltrating immune cells, such as M0 macrophages, neutrophils, resting mast cells, and activated memory CD4+ T cells, than patients in the low‐risk group.